CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline

Authors

Yuetiva Deming, Washington University School of Medicine in St. Louis
Laura Piccio, Washington University School of Medicine in St. Louis
Celeste M. Karch, Washington University School of Medicine in St. Louis
Carlos Cruchaga, Washington University School of Medicine in St. Louis
Katrina Paumier, Washington University School of Medicine in St. Louis
Randall J. Bateman, Washington University School of Medicine in St. Louis
Anne M. Fagan, Washington University School of Medicine in St. Louis
John C. Morris, Washington University School of Medicine in St. Louis
et al

Journal

EMBO Molecular Medicine

Publication Date

2018

Volume

10

Issue

12

Inclusive Pages

e9712

Document Type

Open Access Publication

DOI

10.15252/emmm.2018097121

Rights and Permissions

Suarez-Calvet M, Capell A, Araque Caballero MA, et al (2018) CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline. EMBO Molecular Medicine, 10(12):e9712. DOI: 10.15252/emmm.2018097121 Copyright 2018 The Authors. Published under the terms of the CC BY 4.0 license

Recommended Citation

Deming, Yuetiva; Piccio, Laura; Karch, Celeste M.; Cruchaga, Carlos; Paumier, Katrina; Bateman, Randall J.; Fagan, Anne M.; Morris, John C.; and et al, "CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline." EMBO Molecular Medicine. 10, 12. e9712. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7386